Cargando…
Fighting Tuberculosis: In Search of a BCG Replacement
Tuberculosis is one of the most threatening infectious diseases and represents an important and significant reason for mortality in high-burden regions. The only licensed vaccine, BCG, is hardly capable of establishing long-term tuberculosis protection and is highly variable in its effectiveness. Ev...
Autores principales: | Nadolinskaia, Nonna I., Kotliarova, Maria S., Goncharenko, Anna V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863999/ https://www.ncbi.nlm.nih.gov/pubmed/36677343 http://dx.doi.org/10.3390/microorganisms11010051 |
Ejemplares similares
-
CRISPR/Cas-Based Approaches to Study Schizophrenia and Other Neurodevelopmental Disorders
por: Kurishev, Artemiy O., et al.
Publicado: (2022) -
Vaccines Against Tuberculosis: Problems and Prospects (Review)
por: Nadolinskaia, N. I., et al.
Publicado: (2020) -
CRISPR Interference of Adenylate Cyclases from Mycobacterium tuberculosis
por: Nadolinskaia, N. I., et al.
Publicado: (2021) -
The Impact of Transcriptomics on the Fight against Tuberculosis: Focus on Biomarkers, BCG Vaccination, and Immunotherapy
por: Zárate-Bladés, Carlos Rodrigo, et al.
Publicado: (2011) -
Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic
por: Aspatwar, Ashok, et al.
Publicado: (2021)